Coeptis Therapeutics (COEP) Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy.
According to a recent press release, Coeptis Therapeutics Holdings, Inc. has expanded its exclusive licensing agreement with the University of Pittsburgh
WEXFORD, Pa., Oct. 9, 2023 /PRNewswire/ Coeptis Therapeutics Holdings, Inc. , a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced that Dan.
/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy.